Revive Therapeutics Provides Update of Psilocybin

IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film, microneedle patch and biosynthesis...

Related Keywords

Antigua And Barbuda ,United States ,Canada ,Toronto ,Ontario ,America ,Antigua ,Canadian ,Paul Hutson ,Michael Frank ,Gavin Williams ,Christopher Nicholas ,School Of Medicine ,Therapeutics Ltd ,School Of Pharmacy ,University Of Wisconsin ,Public Health ,Psilocybin International Research ,University Of Health Sciences Antigua ,Pharmather Holdings Ltd ,Psilocin Pharma Corp ,Neither The Canadian Securities Exchange ,Carolina State University ,Regulation Services Provider ,Methamphetamine Use ,Institutional Review Board ,Pharmather Holdings ,North Carolina State University ,Health Sciences Antigua ,Orphan Drug ,Fast Track ,Breakthrough Therapy ,Rare Pediatric Disease ,Canadian Securities Exchange ,Canadian Stock Exchange Rvv Cn ,Revive Therapeutics Ltd ,